AU2002241189A1 - Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides - Google Patents

Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides

Info

Publication number
AU2002241189A1
AU2002241189A1 AU2002241189A AU2002241189A AU2002241189A1 AU 2002241189 A1 AU2002241189 A1 AU 2002241189A1 AU 2002241189 A AU2002241189 A AU 2002241189A AU 2002241189 A AU2002241189 A AU 2002241189A AU 2002241189 A1 AU2002241189 A1 AU 2002241189A1
Authority
AU
Australia
Prior art keywords
polynucleotides
polypeptides
methods
growth factor
stem cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002241189A
Other languages
English (en)
Inventor
Cheng-Chi Chao
John Childs
Radoje T. Drmanac
Ivan Labat
Mitsuo Nishikawa
Y. Tom Tang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kirin Brewery Co Ltd
Original Assignee
Kirin Brewery Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2000/035260 external-priority patent/WO2001053500A1/en
Application filed by Kirin Brewery Co Ltd filed Critical Kirin Brewery Co Ltd
Publication of AU2002241189A1 publication Critical patent/AU2002241189A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Neurosurgery (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2002241189A 2000-12-23 2001-07-25 Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides Abandoned AU2002241189A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PCT/US2000/035260 WO2001053500A1 (en) 1999-12-23 2000-12-23 Methods and materials relating to stem cell growth factor-like poypeptides and polynucleotides
AU2001227385 2000-12-23
PCT/IB2001/002839 WO2002051868A2 (en) 2000-12-23 2001-07-25 Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides

Publications (1)

Publication Number Publication Date
AU2002241189A1 true AU2002241189A1 (en) 2002-07-08

Family

ID=21742103

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002241189A Abandoned AU2002241189A1 (en) 2000-12-23 2001-07-25 Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides

Country Status (5)

Country Link
US (1) US20060074044A1 (enExample)
EP (1) EP1345965A2 (enExample)
JP (1) JP2004518425A (enExample)
AU (1) AU2002241189A1 (enExample)
WO (1) WO2002051868A2 (enExample)

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4491632A (en) * 1979-10-22 1985-01-01 The Massachusetts General Hospital Process for producing antibodies to hepatitis virus and cell lines therefor
US4444887A (en) * 1979-12-10 1984-04-24 Sloan-Kettering Institute Process for making human antibody producing B-lymphocytes
US4341761A (en) * 1980-07-25 1982-07-27 E. I. Du Pont De Nemours And Company Antibodies to immunogenic peptides and their use to purify human fibroblast interferon
US4472506A (en) * 1981-01-13 1984-09-18 Liburdy Robert P Method for determining cell membrane dielectric breakdown
US4466917A (en) * 1981-02-12 1984-08-21 New York University Malaria vaccine
US4493890A (en) * 1981-03-23 1985-01-15 Miles Laboratories, Inc. Activated apoglucose oxidase and its use in specific binding assays
US4451570A (en) * 1981-03-26 1984-05-29 The Regents Of The University Of California Immunoglobulin-secreting human hybridomas from a cultured human lymphoblastoid cell line
US4399121A (en) * 1981-11-04 1983-08-16 Miles Laboratories, Inc. Iodothyronine immunogens and antibodies
US4427783A (en) * 1981-12-14 1984-01-24 Hoffmann-La Roche Inc. Immunoassay of thymosin α1
JP2003529324A (ja) * 1999-06-15 2003-10-07 ジェネンテック・インコーポレーテッド 分泌及び膜貫通ポリペプチドとそれをコードする核酸
US6569662B1 (en) * 2000-01-21 2003-05-27 Hyseq, Inc. Nucleic acids and polypeptides
EP1248848B1 (en) * 1999-12-23 2007-02-28 Kirin Beer Kabushiki Kaisha Methods and materials relating to stem cell growth factor-like poypeptides and polynucleotides
WO2002010217A2 (en) * 2000-08-02 2002-02-07 The Johns Hopkins University Endothelial cell expression patterns

Also Published As

Publication number Publication date
JP2004518425A (ja) 2004-06-24
EP1345965A2 (en) 2003-09-24
WO2002051868A2 (en) 2002-07-04
WO2002051868A3 (en) 2003-05-30
US20060074044A1 (en) 2006-04-06

Similar Documents

Publication Publication Date Title
AU2001274871A1 (en) Methods and materials relating to stem cell factor-like (scf-like) polypeptides and polynucleotides
AU5904101A (en) Methods and materials relating to novel stem cell growth factor-like polypeptides and polynucleotides
IL156234A0 (en) Isolated homozygous stem cells, differentiated cells derived therefrom, and materials and methods for making and using same
AU2002245117A1 (en) In vitro-derived adult pluripotent stem cells and uses therefor
AU2003224702A1 (en) Stem cell selection and differentiation
AU2001290322A1 (en) Fuel cell and production method therefor
AU2001290078A1 (en) Stem cell therapy
AU2001295793A1 (en) Pluripotential stem cells
AU2001247880A1 (en) Methods to prepare and use epidermal stem cells
AU2001233920A1 (en) Improvements in and relating to roof beams
AU2001292318A1 (en) Fuel cell and production method therefor
AU2001227385A1 (en) Methods and materials relating to stem cell growth factor-like poypeptides and polynucleotides
AU2001294010A1 (en) Stem cells
AU6762800A (en) Methods and materials relating to cd39-like polypeptides
AU2001259041A1 (en) Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides
AU2149899A (en) Process for making desired polypeptides in yeast
AU2002323137A1 (en) Methods and compositions for use in selectively producing a protein in telomerase expressing cells
AU2001232967A1 (en) Methods and materials relating to novel growth regulatory-like polypeptides and polynucleotides
AU1782601A (en) Methods and compositions relating to bactericidal/permeability increasing factor-like polypeptides and polynucleotides
AU2001252246A1 (en) Therapeutically active proteins in plants
AU2002360460A1 (en) Methods and materials relating to novel polypeptides and polynucleotides
AU2002333706A1 (en) Method and means for modulating plant cell cycle proteins and their use in plant cell growth control
AU3486501A (en) Methods and materials relating to alpha-2-macroglobulin-like polypeptides and polynucleotides
AU2003259696A1 (en) Methods and materials relating to novel growth regulatory-like polypeptides and polynucleotides
AU2001231288A1 (en) Methods and materials relating to matrix metalloprotease-like polypeptides and polynucleotides

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase